Hands On Webinar | Current Insights into Screening and Prevention

Video Transcription

Video Summary

In today's webinar on diabetes care, Dr. Hiba Ismail and a panel of experts provided insights on screening and prevention of Type 1 diabetes. Discussions included the importance of autoantibody screening, monitoring for metabolic abnormalities, and the use of tools like A1C tests and oral glucose tolerance tests. They emphasized the significance of early detection and intervention to delay the onset of Type 1 diabetes and reduce the risk of diabetic ketoacidosis. The panel also discussed the FDA-approved therapy teplizumab for individuals with Stage 2 Type 1 diabetes, highlighting the need for specialized care and follow-up monitoring. Recommendations were provided for screening high-risk individuals, such as family members of those with Type 1 diabetes, and utilizing resources like TrialNet for screening kits. Strategies for managing patients identified as at risk, including regular monitoring and potential participation in clinical trials, were also addressed. The webinar underscored the importance of personalized care, early intervention, and ongoing support for individuals at risk for Type 1 diabetes.

Keywords

diabetes care

Type 1 diabetes

screening and prevention

autoantibody screening

metabolic abnormalities

A1C tests

oral glucose tolerance tests

teplizumab therapy

high-risk individuals

TrialNet screening kits